Luminera Hydryalix Lips are indicated and used for remodeling and contouring lips with a recommended needle size of 27G.
Luminera’s state of the art technology for the production of Hydryalix, our cross-linked HA line of products, gives the advantages of both monophasic cross-linking and biphasic gel properties.
Monophasic gel, which is homogeneously cross-linked, generates a smooth, uniform gel, lowers side effects, such as swelling and the Tyndall effect, and uses less BDDE for the cross-linking process. The monophasic gel is 100% cross-linked.
The biphasic gel has two phases, a highly cross-linked phase of HA particles and a non-crosslinked HA phase in which the particles are suspended. This noncross linked phase is needed to enable the injection.
The gel is monophasic, fully homogenous, smooth, and easy to inject. The gel is then cut to different particle sizes, generating a line of differentiated products that are intended for diverse indications. The particle nature of the gel gives the ability to mold the injected material to the desired shape in the tissue and gives the product its firmness. A property not found in the standard monophasic products which are available in the market.
Advantages of Luminera Hydryalix Lips
- Marketed since May 2013, with over than 2500 syringes marked so ar
Sound safety profile.
- A safe active ingredient with over 2 decades of marketing experience in dermal fillers
- Biocompatible as well as biodegradable
- marketed in more than 25 countries
- CE certified
- Non animal Origin HA
- Provides a volumizing filling effect
- Also manufactured in the Hybrid MoBi Technology
Composition of Luminera Hydryalix Lips
Sodium Hyaluronate 20 mg / ml cross-linked BDDE
Hydryalix is provided in a 1.5 prefilled graduated syringe